Reducing bone lead content by chelation treatment in chronic lead poisoning: an in vivo X-ray fluorescence and bone biopsy study.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Environmental Research

• Publication date

  1989-02-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/S0013-9351(89)80086-6PMID 2492468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bone lead, hypertension, and lead nephropathy.

  1988cited by this paper
• Bone lead in dialysis patients.

  1988cited by this paper
• Lead nephropathy: In vivo x ray fluorescence (XRF) for assessing body lead stores

  1986cited by this paper
• In vivo bone lead measurements: a rapid monitoring method for cumulative lead exposure.

  1986cited by this paper
• Pharmacokinetics of CaNa2EDTA and chelation of lead in renal failure

  1986cited by this paper
• Decrease of skeletal lead levels in man after end of occupational exposure.

  1986cited by this paper
• In vivo elemental analysis in occupational medicine.

  1986cited by this paper
• In vivo measurement of lead in bone using x-ray fluorescence.

  1985cited by this paper
• Chronic renal failure with gout: a marker of chronic lead poisoning.

  1984cited by this paper
• Lead in finger-bone analysed in vivo in active and retired lead workers.

  1984cited by this paper
• Organic affective illness associated with lead intoxication.

  1984cited by this paper
• Contribution of lead to hypertension with renal impairment.

  1983cited by this paper
• National estimates of blood lead levels: United States, 1976-1980: association with selected demographic and socioeconomic factors.

  1982cited by this paper
• The role of lead in gout nephropathy.

  1981cited by this paper
• The role of lead in gout nephropathy.

  1981cited by this paper
• Uricosuric diuretics.

  1980cited by this paper
• Detection and treatment of occupational lead nephropathy.

  1979cited by this paper
• A comparison of concentrations of lead in human tissues.

  1975cited by this paper
• Chronic lead nephropathy.

  1973cited by this paper

• The effect of chelation on bone Pb stores in Pb poisoned children

  2024influential citation
• Health Effects of Exposure to Specific Geologic Materials: Summary of Clinical Findings, Treatment, and Prevention

  2021cites this paper
• In-lab X-ray fluorescence and diffraction techniques for pathological calcifications

  2016cites this paper
• Estimation of Socio-economic Costs of Illness due to Blood Concentration of Heavy Metals in Koreans among the Public

  2016cites this paper
• Bone Lead Measured by X-ray Fluorescence:

  2016cites this paper
• Lead Mobilization Study and the Clearance of Intravenous CaNa2 EDTA in a Patient With End‐Stage Renal Failure on Hemodialysis

  2012cites this paper
• Lead nephropathy: revisiting an overlooked cause of kidney disease

  2010cites this paper
• Avaliação da influência de diferentes superfícies na adesão e proliferação de osteoblastos humanos

  2010cites this paper
• Toxicological Profile for Lead

  2007cites this paper
• Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.

  2007cites this paper
• ow-level Environmental Exposure to Lead and rogressive Chronic Kidney Diseases a

  2006cites this paper
• Low-level environmental exposure to lead and progressive chronic kidney diseases.

  2006cites this paper
• Lead content in the femoral heads of inhabitants of Silesia (Poland).

  2005cites this paper
• A Review of Chronic Lead Intoxication: An Unrecognized Cause of Chronic Kidney Disease

  2004cites this paper
• Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study.

  2004cites this paper
• Blood lead and chronic kidney disease in the general United States population: results from NHANES III.

  2003cites this paper
• Lead, renal disease and hypertension.

  2002cites this paper
• Chronic Lead Nephropathy with Excessive Body Lead Burden

  2000cites this paper
• Methodological issues related to studies of lead mobilization during menopause.

  1999cites this paper
• Cumulative blood lead levels and neurobehavioral test performance.

  1997cites this paper
• Longitudinal relationship between dentin lead levels in childhood and bone lead levels in young adulthood.

  1996cites this paper
• Partition of circulating lead between serum and red cells is different for internal and external sources of lead.

  1996cites this paper
• Clinical application of in vivo tibial K-XRF for monitoring lead stores.

  1995cites this paper
• Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals.

  1995cites this paper
• 4 – Organ-Specific Therapeutic Intervention

  1995cites this paper
• Bone lead measured by X-ray fluorescence: epidemiologic methods.

  1995cites this paper
• In vivo X-ray fluorescence of lead in bone: review and current issues.

  1994cites this paper
• In vivo x-ray fluorescence measurements of cadmium and lead.

  1993cites this paper
• Lead nephropathy, gout, and hypertension.

  1993cites this paper
• Biological monitoring of inorganic lead.

  1993cites this paper
• In vivo measurements of lead in bone at four anatomical sites: long term occupational and consequent endogenous exposure.

  1992cites this paper
• Bone lead measurements in patients with chronic renal disease studied over time.

  1992cites this paper
• Effect of cocaine use on the fetus.

  1992cites this paper
• Impairment of renal function with increasing blood lead concentrations.

  1992cites this paper
• Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group.

  1992cites this paper
• Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.

  1992cites this paper
• Removing lead from bone: clinical implications of bone lead stores.

  1992cites this paper
• Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone.

  1991cites this paper
• Measurements of trace elements in vivo.

  1990cites this paper
• In Vivo Body Composition Studies

  1990cites this paper
• Hypertension, race, and renal insufficiency.

  1989cites this paper
• Hypertension, Race, and Renal Insufficiency

  1989cites this paper